Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 3, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • disease
  • Page 4

Tag: disease

  • BiotechToday
  • World

LINKAGE BETWEEN HGI AND FAMILY BACKGROUND OF HYPERTENSION

bioxone November 6, 2020November 6, 2020 2

Aishila Kar, Amity University Kolkata Hypertension, along with difficulties like stroke and chronic kidney disease, consumes social and medical wealth. Around 43% of cardiovascular incidents were found to be assigned to hypertension. Haemoglobin glycation index (HGI) is observed to be a convenient measurable indicator to evaluate the individual difference of HbA1c. In the current study, […]

Read More
  • BiotechToday
  • World

Early Response to Influenza Virus in Dendritic Cells

bioxone October 30, 2020October 29, 2020

Thota Kanishka Rao, Amity University Kolkata The influenza infection is related to significant trouble in the human population especially associated with specific danger to kids, the older, and those with certain ailments, for example, pregnancy, obesity, or metabolic disease. Disease with the flu infection triggers a natural immune response pointed toward starting the versatile reaction […]

Read More
  • BiotechToday
  • World

Stem cell-derived human lung organoid model- the next chapter in Viral Disease Research?

bioxone October 20, 2020October 20, 2020

Sampriti Roy, Asutosh College, University of Calcutta SARS-CoV-2, the talk of the town (read “world”), still lacks information related to its origin and exact mechanism.  The virus, found to cause DAD (diffuse alveolar damage), leads to respiratory failure which appears to be the common mechanism of death in patients with severe COVID-19 infection. However, with […]

Read More
  • BiotechToday
  • World

NEW INSIGHTS INTO MALARIA VECTOR IN LAOS COUNTRY

bioxone October 19, 2020October 18, 2020

Aishila Kar, Amity University Kolkata Malaria is the deadliest vector-borne disease worldwide with an average of 228 million cases, and 405,000 deaths in 2018, mainly in the African Region (93%), and the South-East Asia Region (3.4%). In Laos, the malaria burden remains despite a significant reduction of cases during the last decade. In the condition […]

Read More
  • BiotechToday
  • World

Identifying Host Factors to Inhibit Entry of SARS-Cov-2 And Ebola Virus

bioxone October 14, 2020October 14, 2020

Sampriti Roy, Asutosh College (University of Calcutta) When speaking of cell mechanisms, there are still a large number of the same that remain largely unknown. From understanding viral pathogenesis to antiviral therapeutics development – the identification of viral mechanisms and understanding how the virus defends itself is crucial. This is the case particularly for those […]

Read More
  • BiotechToday
  • India

Big breakthrough! ICMR and BIOLOGICAL E LTD develop a potential treatment for Covid-19

bioxone October 2, 2020October 2, 2020 1

-Aishila Kar, Amity University Kolkata The Indian Council of Medical Research (ICMR) in partnership with Hyderabad-based vaccine maker Biological E, has developed a “highly purified antisera” which will be utilized in the prevention and treatment of Covid-19. Antisera are blood sera that carry antibodies against a selected viral toxin or antigen and are introduced to […]

Read More

Posts navigation

1 2 3 4

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy